Pteridines
AssigneeBurroughs Wellcome Co.
InventorAlexander Stuart
Life of this patent
Estimating the term…
Abstract
Novel pteridines of formula (I), ##SPC1## wherein R is a lower alkyl group, substituted with one or more halogen atoms, and R.sup.1 and R.sup.2 are the same or different and each is a lower alkyl group or R.sup.1 and R.sup.2, together with the carbon atom in the pteridine ring structure, form a spirocycloalkyl ring system having 4 to 6 carbon atoms outside the pteridine ring structure; and their method of preparation. The above compounds have bacteriostatic activity.
Claims14
A compound of formula (I), or a tautomeric form thereof, ##SPC5##
- wherein R is a lower alkyl group substituted with one or more halogen atoms, and R.sup.1 and R.sup.2 are the same or different and each is a lower alkyl group or R.sup.1 and R.sup.2, together with the carbon atom in the pteridine ring structure, form a spirocycloalkyl ring system having 4 to 6 carbon atoms outside the pteridine ring structure.
2-Amino-4-hydroxy-6-bromomethyl-7,7-dimethyl-7,8-dihydropteridine or a tautomer thereof.
2-Amino-4-hydroxy-6-dibromomethyl-7,7-dimethyl-7,8-dihydropteridine or a tautomer thereof.
Dependencies are inferred from the claim text.